|
1
|
Hussain SA, Ferry DR, El-Gazzaz G, Mirza
DF, James ND, McMaster P and Kerr DJ: Hepatocellular carcinoma. Ann
Oncol. 12:161–172. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, risk factors, and screening. Semin Liver Dis.
25:143–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases, :
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu B, Sun D, Sun C, Sun YF, Sun HX, Zhu
QF, Yang XR, Gao YB, Tang WG, Fan J, et al: A polymeric
nanoparticle formulation of curcumin in combination with sorafenib
synergistically inhibits tumor growth and metastasis in an
orthotopic model of human hepatocellular carcinoma. Biochem Biophys
Res Commun. 468:525–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Visvader JE: Cells of origin in cancer.
Nature. 469:314–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tork OM, Khaleel EF and Abdelmaqsoud OM:
Altered cell to cell communication, autophagy and mitochondrial
dysfunction in a model of hepatocellular carcinoma: Potential
protective effects of curcumin and stem cell therapy. Asian Pac J
Cancer Prev. 16:8271–8279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu W, Zha W, Ke Z, Min Q, Li C, Sun H and
Liu C: Curcumin protects neonatal rat cardiomyocytes against high
glucose-induced apoptosis via PI3K/Akt signalling pathway. J
Diabetes Res. 2016:41585912016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seto K, Sakabe T, Itaba N, Azumi J, Oka H,
Morimoto M, Umekita Y and Shiota G: A novel small-molecule WNT
inhibitor, IC-2, has the potential to suppress liver cancer stem
cells. Anticancer Res. 37:3569–3579. 2017.PubMed/NCBI
|
|
11
|
Xiao Y, Lin M, Jiang X, Ye J, Guo T, Shi Y
and Bian X: The recent advances on liver cancer stem cells:
Biomarkers, separation, and therapy. Anal Cell Pathol (Amst).
2017:51086532017.PubMed/NCBI
|
|
12
|
Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo
J, Huang H, Du Q, Geller DA and Cheng B: Notch and Wnt/β-catenin
signaling pathway play important roles in activating liver cancer
stem cells. Oncotarget. 7:5754–5768. 2016.PubMed/NCBI
|
|
13
|
Sandur SK, Ichikawa H, Pandey MK,
Kunnumakkara AB, Sung B, Sethi G and Aggarwal BB: Role of
pro-oxidants and antioxidants in the anti-inflammatory and
apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol
Med. 43:568–580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suckow BK and Suckow MA: Lifespan
extension by the antioxidant curcumin in Drosophila melanogaster.
Int J Biomed Sci. 2:402–405. 2006.PubMed/NCBI
|
|
15
|
Yoysungnoen P, Wirachwong P, Changtam C,
Suksamrarn A and Patumraj S: Anti-cancer and anti-angiogenic
effects of curcumin and tetrahydrocurcumin on implanted
hepatocellular carcinoma in nude mice. World J Gastroenterol.
14:2003–2009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masuelli L, Benvenuto M, Fantini M,
Marzocchella L, Sacchetti P, Di Stefano E, Tresoldi I, Izzi V,
Bernardini R, Palumbo C, et al: Curcumin induces apoptosis in
breast cancer cell lines and delays the growth of mammary tumors in
neu transgenic mice. J Biol Regul Homeost Agents. 27:105–119.
2013.PubMed/NCBI
|
|
17
|
Zhang CY, Zhang L, Yu HX, Bao JD and Lu
RR: Curcumin inhibits the metastasis of K1 papillary thyroid cancer
cells via modulating E-cadherin and matrix metalloproteinase-9
expression. Biotechnol Lett. 35:995–1000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun JH, Luo Q, Liu LL and Song GB: Liver
cancer stem cell markers: Progression and therapeutic implications.
World J Gastroenterol. 22:3547–3557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Afrin R, Arumugam S, Rahman A, Wahed MI,
Karuppagounder V, Harima M, Suzuki H, Miyashita S, Suzuki K,
Yoneyama H, et al: Curcumin ameliorates liver damage and
progression of NASH in NASH-HCC mouse model possibly by modulating
HMGB1-NF-κB translocation. Int Immunopharmacol. 44:174–182. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong W, Qian K, Xiong J, Ma K, Wang A and
Zou Y: Curcumin alleviates lipopolysaccharide induced sepsis and
liver failure by suppression of oxidative stress-related
inflammation via PI3K/AKT and NF-κB related signaling. Biomed
Pharmacother. 83:302–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He L, Guo Y, Deng Y, Li C, Zuo C and Peng
W: Involvement of protoporphyrin IX accumulation in the
pathogenesis of isoniazid/rifampicin-induced liver injury: The
prevention of curcumin. Xenobiotica. 47:154–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zabihi NA, Pirro M, Johnston TP and
Sahebkar A: Is there a role for curcumin supplementation in the
treatment of non-alcoholic fatty liver disease? The data suggest
yes. Curr Pharm Des. 23:969–982. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ellerkamp V, Bortel N, Schmid E, Kirchner
B, Armeanu-Ebinger S and Fuchs J: Photodynamic therapy potentiates
the effects of curcumin on pediatric epithelial liver tumor cells.
Anticancer Res. 36:3363–3372. 2016.PubMed/NCBI
|
|
24
|
Bortel N, Armeanu-Ebinger S, Schmid E,
Kirchner B, Frank J, Kocher A, Schiborr C, Warmann S, Fuchs J and
Ellerkamp V: Effects of curcumin in pediatric epithelial liver
tumors: Inhibition of tumor growth and alpha-fetoprotein in vitro
and in vivo involving the NFkappaB- and the beta-catenin pathways.
Oncotarget. 6:40680–40691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duan W, Chang Y, Li R, Xu Q, Lei J, Yin C,
Li T, Wu Y, Ma Q and Li X: Curcumin inhibits hypoxia inducible
factor-1α-induced epithelial-mesenchymal transition in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2505–2510. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiablaem K, Lirdprapamongkol K,
Keeratichamroen S, Surarit R and Svasti J: Curcumin suppresses
vasculogenic mimicry capacity of hepatocellular carcinoma cells
through STAT3 and PI3K/AKT inhibition. Anticancer Res.
34:1857–1864. 2014.PubMed/NCBI
|
|
27
|
Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo
T, Li L, Lin J and Zhang L: Curcumin suppresses proliferation and
induces apoptosis of human hepatocellular carcinoma cells via the
wnt signaling pathway. Int J Oncol. 43:1951–1959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai XZ, Yin HT, Sun LF, Hu X, Zhou C, Zhou
Y, Zhang W, Huang XE and Li XC: Potential therapeutic efficacy of
curcumin in liver cancer. Asian Pac J Cancer Prev. 14:3855–3859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim HJ, Park SY, Park OJ and Kim YM:
Curcumin suppresses migration and proliferation of Hep3B
hepatocarcinoma cells through inhibition of the Wnt signaling
pathway. Mol Med Rep. 8:282–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sa G and Das T: Anti cancer effects of
curcumin: Cycle of life and death. Cell Div. 3:142008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinha D, Biswas J, Sung B, Aggarwal BB and
Bishayee A: Chemopreventive and chemotherapeutic potential of
curcumin in breast cancer. Curr Drug Targets. 13:1799–1819. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhandarkar SS and Arbiser JL: Curcumin as
an inhibitor of angiogenesis. Adv Exp Med Biol. 595:185–195. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dandawate PR, Subramaniam D, Jensen RA and
Anant S: Targeting cancer stem cells and signaling pathways by
phytochemicals: Novel approach for breast cancer therapy. Semin
Cancer Biol 40–41. 1–208. 2016.
|
|
35
|
Subramaniam D, Kaushik G, Dandawate P and
Anant S: Targeting cancer stem cells for chemoprevention of
pancreatic cancer. Curr Med Chem. Jan 26–2017.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gersey ZC, Rodriguez GA, Barbarite E,
Sanchez A, Walters WM, Ohaeto KC, Komotar RJ and Graham RM:
Curcumin decreases malignant characteristics of glioblastoma stem
cells via induction of reactive oxygen species. BMC Cancer.
17:992017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF,
Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, et al: Phase I
clinical trial of curcumin, a chemopreventive agent, in patients
with high-risk or pre-malignant lesions. Anticancer Res.
21:2895–2900. 2001.PubMed/NCBI
|
|
38
|
Dhillon N, Aggarwal BB, Newman RA, Wolff
RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock
R: Phase II trial of curcumin in patients with advanced pancreatic
cancer. Clin Cancer Res. 14:4491–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aggarwal BB, Kumar A and Bharti AC:
Anticancer potential of curcumin: Preclinical and clinical studies.
Anticancer Res. 23:363–398. 2003.PubMed/NCBI
|
|
40
|
Ravindran J, Prasad S and Aggarwal BB:
Curcumin and cancer cells: How many ways can curry kill tumor cells
selectively? AAPS J. 11:495–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bagci EZ, Vodovotz Y, Billiar TR,
Ermentrout GB and Bahar I: Bistability in apoptosis: Roles of bax,
bcl-2, and mitochondrial permeability transition pores. Biophys J.
90:1546–1559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eissing T, Waldherr S, Allgöwer F,
Scheurich P and Bullinger E: Response to bistability in apoptosis:
Roles of bax, bcl-2, and mitochondrial permeability transition
pores. Biophys J. 92:3332–3334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Estaquier J, Vallette F, Vayssiere JL and
Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med
Biol. 942:157–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wurstle ML, Laussmann MA and Rehm M: The
central role of initiator caspase-9 in apoptosis signal
transduction and the regulation of its activation and activity on
the apoptosome. Exp Cell Res. 318:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Y, Kong Y, Liu S, Zeng L, Wan L and
Zhang Z: Curcumin induces apoptosis in human leukemic cell lines
through an IFIT2-dependent pathway. Cancer Biol Ther. 18:43–50.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang C, Zhang X, Teng Z, Zhang T and Li Y:
Downregulation of PI3K/Akt/mTOR signaling pathway in
curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur J
Pharmacol. 740:312–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu X, Qin J and Liu W: Curcumin inhibits
the invasion of thyroid cancer cells via down-regulation of
PI3K/Akt signaling pathway. Gene. 546:226–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen WC, Lai YA, Lin YC, Ma JW, Huang LF,
Yang NS, Ho CT, Kuo SC and Way TD: Curcumin suppresses
doxorubicin-induced epithelial-mesenchymal transition via the
inhibition of TGF-β and PI3K/AKT signaling pathways in
triple-negative breast cancer cells. J Agric Food Chem.
61:11817–11824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiao D, Wang J, Lu W, Tang X, Chen J, Mou
H and Chen QY: Curcumin inhibited HGF-induced EMT and angiogenesis
through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways
in lung cancer. Mol Ther Oncolytics. 3:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lopes-Rodrigues V, Oliveira A,
Correia-da-Silva M, Pinto M, Lima RT, Sousa E and Vasconcelos MH: A
novel curcumin derivative which inhibits P-glycoprotein, arrests
cell cycle and induces apoptosis in multidrug resistance cells.
Bioorg Med Chem. 25:581–596. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J,
Jin R, Zhao C and Liang G: Curcumin sensitizes human gastric cancer
cells to 5-fluorouracil through inhibition of the NFκB
survival-signaling pathway. Onco Targets Ther. 9:7373–7384. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cianciulli A, Calvello R, Porro C, Trotta
T, Salvatore R and Panaro MA: PI3k/Akt signalling pathway plays a
crucial role in the anti-inflammatory effects of curcumin in
LPS-activated microglia. Int Immunopharmacol. 36:282–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zheng R, Deng Q, Liu Y and Zhao P:
Curcumin inhibits gastric carcinoma cell growth and induces
apoptosis by suppressing the Wnt/β-catenin signaling pathway. Med
Sci Monit. 23:163–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Prasad CP, Rath G, Mathur S, Bhatnagar D
and Ralhan R: Potent growth suppressive activity of curcumin in
human breast cancer cells: Modulation of Wnt/β-catenin signaling.
Chem Biol Interact. 181:263–271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang J, Wang C, Zhang Z, Chen X, Jia Y,
Wang B and Kong T: Curcumin inhibits the survival and metastasis of
prostate cancer cells via the Notch-1 signaling pathway. APMIS.
125:134–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tong W, Wang Q, Sun D and Suo J: Curcumin
suppresses colon cancer cell invasion via AMPK-induced inhibition
of NF-κB, uPA activator and MMP9. Oncol Lett. 12:4139–4146. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dai C, Lei L, Li B, Lin Y, Xiao X and Tang
S: Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling
pathways and endoplasmic reticulum stress in furazolidone induced
cytotoxicity and S phase arrest in human hepatocyte L02 cells:
Modulation of curcumin. Toxicol Mech Methods. 27:165–172. 2017.
View Article : Google Scholar : PubMed/NCBI
|
